Jack B. Blumenfeld

Jennifer H. Roscetti

Megan Dellinger

Danielle A. Duszczyszyn

Jeremy A. Tigan

William B. Raich

Ryan McDonnell

Constance Pei Hwa Lee

Reinaldo F. Machin

Third suit in ANDA clash: AbbVie hits Hetero with newly issued patents to protect its ORILISSA® drug over `heavy menstrual bleeding` treatment methods.

Prosecution History analysis

Examiner Search analysis

Invalidity Framework analysis

Hetero Labs Ltd

Hetero USA Inc

Abbvie US LLC

Last Docket Entry Date

Total Docket Entries

United States District of Delaware

1:24-cv-00151 | AbbVie Inc v. Hetero Labs Ltd | Ex Parte

Name	Ratings
Morris Nichols Arsht & Tunnell LLPLocal	L5 A
Jack B. Blumenfeld	L5 A
Jeremy A. Tigan	L5 A
Megan Dellinger	L5 A
Finnegan Henderson Farabow Garrett & Dunner LLP	L5 A
Jennifer H. Roscetti	L3 B
William B. Raich	L2 A
Danielle A. Duszczyszyn	L2 C
Constance Pei Hwa Lee	L1 C
Ryan McDonnell	L1 D
Reinaldo F. Machin	-- -- --

Name	Ratings
Hetero Labs Ltd	L4 E
Hetero USA Inc	L4 E